Blue Horseshoe Stocks: IZEA, ITUS Recaps & More

ITUS Corp. ITUS 

We included a tag of ITUS in this past Thursday’s premarket report, after noticing the stock’s liquidity and price action increasing in a big way in the sessions leading up to that.

Despite already seeing big moves to that point, it was just the start for the excellent run made by this stock in the last three sessions. We observed a low of 1.92 in ITUS on Thursday, and yesterday the stock reached a new high of 4.30. That represents a three-day swing of 124%

Volume over the same period has been vastly greater than average. The whole trend was catalyzed when the company updated shareholders on its cancer detection technology, on the morning of our initial alert.


Helios and Matheson Analytics, Inc. HMNY

We’ve been tracking HMNY since  August 15th, where-after we witnessed a low of 2.42.
We were just mentioning this, and the fantastic multi-bag moves the stock has made since, in yesterday’s premarket report. We also mentioned that based on the previous close, that we’d “look for the continued establishment of higher highs and higher lows.”

Despite already having gone up so much in the course of the last five weeks, the stock’s excellent performance yesterday did push it to new highs yet again. In fact, it streaked all the way to 9.65, representing an overall move of 299% since we began tracking its activity.


IZEA, Inc. IZEA

We also want to reiterate our signal on IZEA yesterday, which made a move of 40% in trading up from its morning low of 4.54 to a high of 6.35. It was a respectable gain, but this morning the stock is gapping up and pushing the $7-mark, so we’ll jeep our eyes peeled for the possibility of a more sustained uptrend.


Apple, Inc. AAPL – Options Idea

With the hint of a reversal and rebound after a rapid weeks-long selloff in AAPL, combined with a premarket gap-up this morning, we’d like to signal a range of AAPL calls to coincide with the activity and possibly help us find some quick-strike trade opportunities. We’ll radar the AAPL Weekly $150-155 Calls to try to do just that.


Extended Watchlist:
INPX, ASNA, MBRX, CDXC, FCSC, TEUM, MYSZ

Blue Horseshoe Stocks: DCTH Review & More

Delcath Systems, Inc. DCTH
We flagged DCTH in Friday’s premarket reportas a prime bottom-bounce candidate that could be in line for a serious rebound, and even despite the markets as a whole taking a gut punch, it ended up being a great single-session play, and the NASDAQ’s top gainer.

From an early low of .0501 the stock surged as high as .0845, which works out to an intraday rise of 69% and it occurred on more than ten times the 30-day average volume, with DCTH logging its second-highest daily volume of all time.

We’d say our timing was extremely fortuitous on this rebound play, and with the kind price action and liquidity that we witnessed Friday, we’ll definitely be interested to see how the action unfolds to kick off this new trading week.


TrovaGene, Inc. TROV

We wanted to make mention of TROV this morning after noticing a cherry of a PR buzzing over the newswires. The company announced an agreement to provide tests and services for pharma giant AstraZeneca.

Whenever we see one of these smaller pharma company’s have joint news with a big player in the sector, we always want to pay attention to the stock. A perfect example of this is Pieris Pharmaceuticals, Inc. PIRS, which we signaled back on May 4th when that company also had news tying it to none other than AstraZeneca. What followed was a 55% run lasting nearly a month that took it from 3.26 the following day to a high of 5.06 last Monday, the 31st.

On the chance that TROV experiences a similar bullish push on the heels of its own AstraZeneca announcement, we’re going to be sure to have this one on watch in coming sessions.


Ascena Retail Group, Inc. ASNA

We’re also taking notice of a nice technical setup on ASNA, which owns the Lane Bryant retail brand among others, and was another of the NASDAQ’s top gainers of the day on Friday.

The activity came in the wake of a rather disappointing earnings release in terms of financials, but investors clearly responded well to the company outlook moving forward.

As you can see on the included snapshot, the stock picked up speed in its recent ascent off of a bottom, and began to fill a gap on the chart to the upside. We also have a number of other indicators pointing to a possible continued uptrend, so we’ll afford this stock a slot on our watchlist.


Extended Watchlist:
XBIT, DXTR, RWLK, ABIL, ADHD, ENRJ